Table 1 Demographic and HIV-related parameters
Tolerability Study Group | HIV infected patients vaccinated against pandemic influenza in the two centres who returned their patient's diary | |
|---|---|---|
Acceptance Study Group | HIV infected patients, eligible for active immunization, who visited the Cologne outpatient clinic in the predefined time period | |
SD | Standard deviation | |
ART | Antiretroviral therapy | |
Tolerability Study Group | Acceptance Study Group | |
N (total) | 475 | 538 |
Male:Female | 387:88 | 447:91 |
Mean age, years (SD) | 45 ( ± 9) | 45 ( ± 9) |
Caucasian, N (%) | 404 (85%) | 453 (84%) |
Mean absolute CD4-cells/ μl (SD) | 498 ( ± 194) | 483 ( ± 177) |
HIV-RNA < 50 copies/ ml, N (%) | 336 (77%) | 393 (73%) |
ART treatment, N (%) | 412 (87%) | 462 (86%) |